UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000021014 |
|---|---|
| Receipt number | R000023692 |
| Scientific Title | Feasibility study to evaluate efficacy and safety of laparoscopic radical histerectomy in Kanazawa University Hospital. |
| Date of disclosure of the study information | 2016/02/15 |
| Last modified on | 2023/08/29 09:00:21 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Feasibility study to evaluate efficacy and safety of laparoscopic radical histerectomy in Kanazawa University Hospital.
Acronym
Feasibility study to evaluate efficacy and safety of laparoscopic radical histerectomy in Kanazawa University Hospital.
Scientific Title
Feasibility study to evaluate efficacy and safety of laparoscopic radical histerectomy in Kanazawa University Hospital.
Scientific Title:Acronym
Feasibility study to evaluate efficacy and safety of laparoscopic radical histerectomy in Kanazawa University Hospital.
Region
| Japan |
Condition
Condition
Cervical cancer stage IA2,IB1 and IIA1
Classification by specialty
| Obstetrics and Gynecology |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
Objective of this study is to evaluate efficacy and safety of laparoscopic radical hysterectomy for cervical cancer in Kanazawa University Hospital.
Basic objectives2
Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Frequency of perioperative complication(beyond grade2)
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Female
Key inclusion criteria
Patient is pathologically diagnosed as cervical cancer.
Patient is clinically staged as IA2,IB1 or IIA1.
We need to obtain written informed consent by the patient.
Patient condition is acceptable for general anesthesia.
Key exclusion criteria
Patient has psycological disorder unacceptable to participate in the trial.
When the physician determined the patient is inadequate for the trial
Target sample size
3
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Hiroshi Fujiwara |
Organization
Kanazawa Univ. Hospital
Division name
Dept. of OB/GYN
Zip code
Address
13-1 Takara-machi Kanazawa-si Ishikawa-ken Japan
TEL
076-265-2425
sanpu@med.kanazawa-u.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Yasunari Mizumoto |
Organization
Kanazawa Univ. Hospital
Division name
Dept. of OB/GYN
Zip code
Address
13-1 Takara-machi Kanazawa-si Ishikawa-ken Japan
TEL
076-265-2425
Homepage URL
yas1025@med.kanazawa-u.ac.jp
Sponsor or person
Institute
Dept. of OB/GYN,Kanazawa Univ. Hospital
Institute
Department
Personal name
Funding Source
Organization
Kanazawa Univ. Hospital
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2016 | Year | 02 | Month | 15 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Terminated
Date of protocol fixation
| 2015 | Year | 04 | Month | 23 | Day |
Date of IRB
| 2015 | Year | 04 | Month | 23 | Day |
Anticipated trial start date
| 2016 | Year | 02 | Month | 18 | Day |
Last follow-up date
| 2020 | Year | 12 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
prospective observational study
Recruitment of the subjects :
3 female patients matched to the inclusion criteria,who visited our facility after April 2015
Management information
Registered date
| 2016 | Year | 02 | Month | 14 | Day |
Last modified on
| 2023 | Year | 08 | Month | 29 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023692
